Research Analysts Issue Forecasts for Teleflex Q1 Earnings

Posted by George Bondi on May 12th, 2026

Teleflex Incorporated (NYSE:TFX – Free Report) – Equities researchers at Needham & Company LLC issued their Q1 2028 earnings per share estimates for shares of Teleflex in a research note issued to investors on Friday, May 8th. Needham & Company LLC analyst M. Matson expects that the medical technology company will post earnings of $2.90 per share for the quarter. Needham & Company LLC has a “Buy” rating and a $147.00 price objective on the stock. The consensus estimate for Teleflex’s current full-year earnings is $6.75 per share. Needham & Company LLC also issued estimates for Teleflex’s FY2028 earnings at $12.18 EPS.

Several other brokerages have also commented on TFX. Zacks Research raised Teleflex from a “strong sell” rating to a “hold” rating in a research report on Tuesday, April 28th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Teleflex in a research report on Friday, March 27th. Mizuho set a $140.00 price target on shares of Teleflex in a research report on Friday. Truist Financial reissued a “hold” rating and set a $143.00 price objective (up from $135.00) on shares of Teleflex in a research note on Monday. Finally, Wells Fargo & Company upped their price objective on shares of Teleflex from $130.00 to $138.00 and gave the stock an “equal weight” rating in a report on Friday. Three investment analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, Teleflex has a consensus rating of “Hold” and a consensus price target of $144.00.

View Our Latest Analysis on Teleflex

Teleflex Price Performance

Shares of TFX stock opened at $129.92 on Tuesday. The business’s fifty day moving average is $120.08 and its 200 day moving average is $116.73. The company has a quick ratio of 2.03, a current ratio of 2.55 and a debt-to-equity ratio of 0.82. The stock has a market cap of $5.75 billion, a price-to-earnings ratio of -5.70, a PEG ratio of 0.96 and a beta of 0.82. Teleflex has a twelve month low of $100.18 and a twelve month high of $139.67.

Teleflex (NYSE:TFX – Get Free Report) last announced its earnings results on Thursday, May 7th. The medical technology company reported $1.39 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.21 by $0.18. The firm had revenue of $548.30 million during the quarter, compared to analyst estimates of $536.91 million. Teleflex had a positive return on equity of 13.29% and a negative net margin of 35.88%.The business’s revenue was up 32.3% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.44 EPS. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS.

Teleflex Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 31st. Investors of record on Friday, March 6th were issued a $0.34 dividend. The ex-dividend date was Friday, March 6th. This represents a $1.36 annualized dividend and a yield of 1.0%. Teleflex’s dividend payout ratio (DPR) is currently -5.96%.

Institutional Investors Weigh In On Teleflex

A number of large investors have recently made changes to their positions in TFX. Banque Cantonale Vaudoise increased its holdings in Teleflex by 82.5% during the fourth quarter. Banque Cantonale Vaudoise now owns 250 shares of the medical technology company’s stock valued at $31,000 after buying an additional 113 shares during the last quarter. Hantz Financial Services Inc. lifted its holdings in Teleflex by 248.8% during the third quarter. Hantz Financial Services Inc. now owns 279 shares of the medical technology company’s stock valued at $34,000 after purchasing an additional 199 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. bought a new position in shares of Teleflex in the third quarter worth approximately $35,000. V Square Quantitative Management LLC purchased a new stake in shares of Teleflex in the fourth quarter worth $37,000. Finally, Quent Capital LLC purchased a new stake in shares of Teleflex in the third quarter worth $38,000. 95.62% of the stock is currently owned by institutional investors.

Key Headlines Impacting Teleflex

Here are the key news stories impacting Teleflex this week:

Positive Sentiment: Needham & Company reiterated a Buy rating on Teleflex and set a $147 price target, while projecting FY2028 EPS of $12.18 and Q1 2028 EPS of $2.90, signaling confidence in longer-term earnings growth. Needham & Company Teleflex estimate report
Positive Sentiment: Citizens JMP also raised its earnings expectations, forecasting FY2027 EPS of $10.50 and quarterly EPS of $2.03, $2.62, $2.83, and $3.05 for 2027, which suggests analysts see meaningful profit expansion ahead. Citizens JMP Teleflex estimate report
Neutral Sentiment: Truist Financial reaffirmed a Hold rating but lifted its price target to $143 from $135, implying moderate upside without a strong bullish shift. Teleflex Hold rating reaffirmed at Truist Financial

About Teleflex

(Get Free Report)

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.